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We consider a method for extending instrumental variables methods in order to estimate the
overall effect of a treatment or exposure. The approach is designed for settings in which the
instrument influences both the treatment of interest and a secondary treatment also influenced by
the primary treatment. We demonstrate that, while instrumental variables methods may be used to
estimate the joint effects of the primary and secondary treatments, they cannot by themselves be
used to estimate the overall effect of the primary treatment. However, instrumental variables
methods may be used in conjunction with approaches for estimating the effect of the primary on
the secondary treatment to estimate the overall effect of the primary treatment. We consider
extending the proposed methods to deal with confounding of the effect of the instrument,
mediation of the effect of the instrument by other variables, failure-time outcomes, and time-
varying secondary treatments. We motivate our discussion by considering estimation of the overall
effect of the type of vascular access among hemodialysis patients.
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1 Introduction
Instrumental variables (IV) methods have been used successfully to control for
confounding in a number of settings in which conventional methods fail (Davey Smith
and Ebrahim, 2003; Mark and Robins, 1993; McClellan and Newhouse, 1997).  IV
methods may be used in estimating the component and joint effects of multiple
treatments or exposures (Stock, 2001).  However, when one of the treatments under
study affects another, IV methods will not by themselves provide valid estimates of
the overall effect of the former.  We consider extension of IV methods that allow
estimation of the overall effects of the initial treatment.  
For motivation, we consider estimating the overall effects of type of vascular
access (VA) among hemodialysis (HD) patients on clinical outcomes (e.g., mortality).
VA can affect the dose of dialysis received (Sehgal et al., 1998; Dhingra, Young,
Hulbert-Shearon, Leavey and Port, 2001).  The clinical center at which dialysis is
provided may be a good instrument for the joint effects of VA and dose, but, as we
will argue, it is not an instrument for the overall effect of VA.  We will thus need to
use extended IV methods. 
This manuscript is organized as follows.  First, we consider the VA problem
in more detail.  Then, using both graphical and counterfactual approaches to causality,
we show how, under our assumptions, IV methods are appropriate for estimating the
component and joint effects of VA and dose (the earlier and later treatments), but not
the overall effect of VA (the earlier treatment).  We then show how to estimate the
overall effect, and consider extensions to situations with confounders or additional
mediators of the effect of the instrument, to failure-time outcomes, and to time-
varying auxiliary treatments. 
2 Vascular access in hemodialysis
Hemodialysis (HD) is one of the principal modalities of renal replacement therapy in
end-stage renal disease (ESRD), a condition in which a person’s kidneys no longer
function adequately.  In HD, blood is removed from the body, filtered, and then
returned to the vascular system.  This process requires access to the vascular system.
This access can take the form of a catheter, implantation of synthetic material between
an artery and vein (graft), or a native arteriovenous fistula.
The type of VA can impact the dose of dialysis that can be delivered, and thus
can influence the dose of dialysis actually received.  VA may influence clinical
outcomes, including mortality (Dhingra et al. 2001; Wolfe, Dhingra, Hulbert-Shearon,
Leavey and Port, 2000).  A good part of the effect of VA may be mediated by
delivered dialysis dose.  Type of VA may affect clinical outcomes by other pathways
as well.
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In ESRD, many of the treatments used to treat various aspects of ESRD or
its consequences are subject to confounding by indication (Feldman et al., 2004;
Reddan et al., 2002), i.e., subjects with an indication for a particular treatment often
have more severe disease than other subjects.  There are a number of reasons that
patients who receive dialysis catheters may be sicker than those who are treated via
fistula or graft.  Fistula/graft creation requires vascular surgery, and patients with
more comorbid disease often are not surgical candidates.  In addition, fistulas and
grafts require suitably healthy vascular systems, which may not be present in older,
frailer patients or those with extensive cardiovascular disease.  Finally, grafts and,
particularly, fistulas require time to mature after they are placed and before they are
ready for use, whereas catheters are ready instantaneously upon placement.  Patients
with less access to health care, and who therefore are less likely to receive care for
other diseases, are less likely to present in time to receive fistulas or grafts, and more
likely to receive catheters.  
Confounding by indication is often difficult to control analytically using
standard methods, e.g., regression.  IV analysis provides an alternative approach to
controlling confounding.  For this method to work, the instrumental variable should
be related to the outcome only through its effect on the treatment(s) of interest.  The
center at which dialysis is provided is a plausible candidate for an instrument.  The
choice of center for dialysis patients might be expected to be driven primarily by
factors not intimately related to prognosis, such as geographical proximity of the
patient to the center.  Inasmuch as center is not strongly associated with prognosis,
center may fulfill the criterion for an instrumental variable that it only be related to the
outcome through its effect on the treatment(s) of interest; this criterion has implicitly
been used to provide causal interpretation to associations between average levels of
compliance within centers to guidelines about dialysis dose and hematocrit with
center-specific mortality (Wolfe, Hulbert-Shearon, Ashby, Mahadevan and Port,
2004).  For similar reasons, we propose using center as an instrument for estimating
the effect of VA type on outcome.
3 The effect of vascular access
To define our problem, it is useful to consider the various pathways by which the
primary treatment (VA) might affect clinical outcomes, and other ways associations
between the primary treatment and outcome might be generated.  Causal diagrams
(Pearl, 1995; Pearl, 2000) are useful for this purpose.  We will consider these
diagrams together with formal definitions of effects based on the potential outcomes
model (Rubin, 1974; Rubin, 1978; Neyman, 1990).
We begin with a simple diagram showing relations between the main variables
of interest (Figure 2).  Let A denote the primary treatment (type of VA), S denote the
2
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auxiliary treatment (dose of dialysis), and Y the clinical
outcome of interest (e.g., mortality).  We presume that
A affects S, thus we draw an arrow from A to S ( ).
The auxiliary treatment (dialysis dose) may affect clinical
outcomes ( ).  Further, the primary treatment may
affect clinical outcomes directly (i.e., through pathways
not containing S), thus, we also draw an arrow .
The overall impact of the primary treatment (VA) on
clinical outcomes is represented by considering both
paths from A to Y (i.e.,  and ).  The direct
effect of the primary treatment (VA), controlling for the
auxiliary treatment (dialysis dose), is represented by the
path ; the indirect effect is represented by the path
.  In our example, because VA can determine the
dose of dialysis, the indirect path  cannot be
ignored in assessing the impact of VA on outcome. 
We supplement the causal diagrams with a potential outcomes approach to
more formally define overall, direct, and indirect effects (Pearl, 2001; Robins and
Greenland, 1992).  Let  denote the outcome that would be seen in a subject were
that person to receive level a of the primary treatment and level s of the auxiliary
treatment.  denotes the value that S would assume were treatment level a
provided, without S being manipulated by the investigator.   is the outcome that
would be seen were the investigator to provide primary treatment a but leave the
choice of S subject to the same possibly unknown factors governing it during the
study; thus, under a consistency assumption (Robins and Rotnitzky, 2004), .
Overall effects of A are contrasts of  and , .  The direct effect of A is a
contrast of  and , i.e, a contrast of outcomes holding s physically constant but
varying a.  There are several direct effects, depending on the choice of s. Prescriptive
direct effects require prespecification of s; for natural direct effects, s is the value it
would assume under a reference level  of the primary treatment A, i.e., .
Natural indirect effects are contrasts of  and ,i.e., allow S to vary as it
would by varying A, but fix A to some common value.  There is no nonparametric
definition of prescriptive indirect effects, although there are several definitions based
on parametric models (MacKinnon, Lockwood, West and Sheets, 2002).    
In our example, because the type of access determines to a degree the possible
dose of dialysis, in ascertaining the impact of VA, we cannot simply control or adjust
for dose.  Thus, we will concentrate on estimating the overall impact of VA.
Figure 1.  Causal
diagram showing
relations between key
treatments and
outcomes.
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However, the direct and indirect effects will be of interest, not only for mechanistic
understanding and explanation, but also for deriving estimates of the overall effect.
4 Identification and estimation
To understand appropriate approaches for estimation, we supplement the causal
diagram (Figure 2) with other variables.  In particular, we add both measured (X) and
unmeasured (U) confounders of the effect of A and S; X and U influence A, S, and Y.
The presence of unmeasured confounders makes standard adjustments for
confounders X inadequate for estimating
the effects of A and S.  We also add a
node for an instrumental variable (IV) R,
whose association with outcome is
presumed to be solely due to its effect on
A and S.  As with other IVs, R influences
treatment (A and S), but has no direct
effect on Y (no  arc, i.e., an
exclusion restriction (Angrist, Imbens
and Rubin, 1996) holds), and there are
no unmeasured common causes of R and
Y.  Figure 2 represents these
relationships.
In this setup, R is an instrument
for the joint effects of A and S but not for
the overall effect of A.  To see this, note
that R is d-separated from Y in the graph
removing the effects of A and S (i.e., the
arrows out of A and S), and A and S are
affected by R; R then satisfies graphical
criteria (Pearl 2000) but not necessarily standard econometric criteria for an
instrument.  Suppose we assume a linear, no interaction model for the effect of A and
S on Y:
We call this a structural model, as it models the relations between the structural
variables  and ; as expressed in (1), this is a rank-preserving structural nested
(distribution) model (Robins, Blevins, Ritter and Wulfsohn, 1992; Robins, Rotnitzky
and Scharfstein, 2000; Ten Have et al., 2007).  Using standard theory (Joffe and
Figure 2. Augmented causal diagram
showing relations between instrument,
confounders, key treatments, and
outcomes.
(1)
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Greene, 2007), we have that, if R is unassociated with the potential outcome  (as
it would be if there are no unmeasured common causes of R and Y), 
where V is a selected subset of the elements in X.  Under linear model assumptions,
we substitute  for .   and  are unknown but may be
estimated.  The design matrix made up of V, , and  must be of full
rank to estimate this model using standard methods (e.g., least squares).  If R is
binary, we need some covariates in V (and, if linear models are used for  and
, an interaction R*V in at least one of those models) to achieve this.  If R has
more than 2 levels, a full rank design matrix may be achievable even if V is the empty
set; here, R may be operationalized as a series of dummy variables.  Two-stage least
squares (2SLS) may be used for the estimation (Albert, 2007).  
Semiparametric estimation of  using G-estimation is also possible
(Robins and Greenland, 1994; Joffe, Small and Hsu, 2007; Ten Have, Elliott, Joffe,
Zanutto and Datto, 2004; Ten Have et al. 2007).  Heuristically, G-estimation is based
on the fact that, under our assumptions, the potential outcome  is independent of
the instrument R.  Under (1), we can compute a value for  under an assumed
causal theory  by removing the effects of A and S as .  Point
and interval estimation are based on tests of the independence of  and R.
Unlike 2SLS, consistency of G-estimation does not depend on correct specification
of the model for .
5 Estimation of overall effects
In contrast to the component effects of A and S, the overall effect of A cannot be
estimated using standard IV methods alone.  To see this, we consider graphical
criteria (Pearl 1995; Pearl 2000).  The path  is not blocked by A; therefore,
A does not d-separate R and Y (in the graph in which the effects of A is blocked; i.e.,
the arrows out of A are removed)  and so R is not an instrument.  Loosely speaking,
part of the effect of R on Y is not mediated by A.
To estimate the overall effect of A on Y, we can combine our estimates of the
joint effects of A and S on Y with estimates, which we now consider, of the effect of
A on S.  Under our assumptions, the effect of A on S is confounded by R, X, and U;
(2)
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therefore, even controlling for the measured variables R and X will not be sufficient
to obtain valid estimates.  Instead, we consider a two-stage least squares estimating
procedure, in which we will also estimate the direct effect or influence of R on S
controlling for A.  Let  denote the level of S that would be observed were we to
set R to r and A to a; , discussed earlier, may be taken to equal .  Suppose first
that we can use a linear structural model for the effect of R and A on S:
Then, write 
where W, like V, includes a subset of the variables in X .  As before (section 4),  is
estimable if the design matrix in the regression of S on R, W, and  has full
rank.  If  follows a linear no-interaction model (Joffe and Greene 2007)
and R is ignorable (i.e., ) (Rosenbaum and Rubin, 1983), we have
and then the model for  must include an R by W interaction if a linear model
is used (Albert 2007; Ten Have et al. 2007).
Under our linear no-interaction models ((1),(3)), all the direct effects of A are
the same as each other, i.e., natural effects do not depend on the reference level of A,
prescriptive effects do not depend on the reference level of S, and natural and
prescriptive effects are the same.  In this setting, the overall effect of treatment 
may be calculated as
We estimate  by plugging into (5) estimates of  and  from the 2SLS
approach in Section 4 and  from the 2SLS approach in this section, and call this
the extended 2SLS estimate.  Standard errors for the extended 2SLS estimates of 
may be calculated analytically, or using a nonparametric bootstrap.  Appendix 1
(3)
(4)
(5)
(6)
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provides analytic formulas for the standard errors from the extended 2SLS approach,
and compares these to a three-stage least squares (3SLS) approach, which can be
more efficient under certain conditions.
6 Simulation study 
We performed a small simulation study to examine the properties of the various
estimators.  Consider a setting where W consists of two variables that are generated
as independent standard normals, there are 500 subjects and the parameters are the
following (see Appendix 1 for definitions of  and ): , ,
, , , , , , ,
. The total effect of A is .
Table 1 shows the bias and root mean square error of the path analysis
estimate of the effect of A (which assumes no unmeasured confounding), the estimate
of the total effect of A based on 2SLS, and the estimate of the total effect of A based
on 3SLS in 2000 simulations.  The 2SLS and 3SLS estimates performed virtually
identically.  The coverage of the 95% confidence intervals based on  from the
simulation study was 0.9500 for the 2SLS approach and 0.9485 for the 3SLS
approach.
Table 1.  Bias and root mean square error (RMSE) of various estimators of  in two
different scenarios.
Estimator Bias RMSE
Scenario 1: ( )
Path Analysis 0.872 0.872
2SLS -0.001 0.122
3SLS  0.002 0.122
Scenario 2: ( )
Path Analysis 0.970 0.970
2SLS 0.000 0.051
3SLS 0.001 0.039
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The 3SLS estimates can provide efficiency gains in other situations in which
different instruments are used for S compared to Y (this is analogous to the fact that
seemingly unrelated regression (SUR) provides efficiency gains when the different
equations have some different covariates, whereas SUR provides no efficiency gains
if all the equations have exactly the same covariates).  If we use the same simulation
setting as above but assume that the second component of W is an instrument for S
but not Y and let , then the estimation results are shown in the second
scenario in Table 1.  The root mean squared error of the 3SLS estimate is 24% less
than that of the 2SLS estimate for this scenario.
7 Extensions
We consider four extensions to this framework:
1. the presence of confounders of the effect of R on Y;
2. the presence of additional measured mediators of the “effect” of R on Y;
3. the use of failure-time outcomes instead of outcomes measured at a fixed
time; and
4. settings in which the intermediate S is not fixed but rather time-varying. 
7.1 Confounders of the instrument
Until now, we have supposed that
associations between the instrument and
outcome can be explained fully in terms of
the associations of the instrument with the
specified treatments A and S and the
effects of those treatments on the
outcome.  In this and the following
subsection, we weaken this requirement by
allowing the instrument R to be associated
with some other variable associated with
the outcome.  In some cases, this variable
will be a confounder of the effect of R; in
others, an intermediate treatment on a path
from R to Y not involving A or S. 
Suppose first that there are
individual characteristics X that are
associated with the instrument and the
outcome (Figure 3).  For example, it is
Figure 3. Causal diagram 2,
augmented to allow confounding of
effect of instrument by measured
variables.
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possible that patients initiating dialysis at some centers are sicker, have higher income
or education, or are older than patients initiating dialysis at other centers.  These
associations may lead to associations between the putative instrument R and outcome
Y even in the absence of any effects of the treatments A and S on Y.
For estimation, the same extended 2SLS approach taken previously is
appropriate here, so long as appropriate confounders of the associations of the
instrument R with Y and S are considered in the appropriate models.  In particular, the
effects of A and S on Y are estimable using (2) so long as ; that
is, if R is an instrument for the effects of A and S conditional on V.  Thus, any
common causes of R and  must be included in V.  Similarly, the effect of A on S
is estimable using (4) and (5) if those models are correctly specified and there are no
unmeasured common causes of R and ; here, all measured common causes of R
and S must be included in W.
7.2 Additional mediators of the effect of the instrument
In our motivating example, center (R) is associated with a variation in a wide range
of treatment patterns.  For example, practice may affect dosing of erythropoetin and
intravenous iron, both of which are used for treating the anemia prevalent among HD
patients and which may affect other clinical outcomes, including mortality.  Q denotes
these additional mediating variables.  We augment our causal graph to show these
additional paths from R to Y, as well as paths from U and X to R (Figure 4).  The
approach sketched below will also be appropriate if Q affects A and S (i.e., additional
arcs  and  are added to Figure 4).
For estimation, we augment our causal model (1) with a term for the effect of
Q:
This again implies that 
Estimation can again proceed using 2SLS; we now require that the design matrix
comprised of V, , , and  have full rank.  Estimating the
effect of A on S can proceed as previously, as can combining inferences for the overall
(7)
(8)
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effect from the models for S and
Y.  The approach above
allows  as a special case.
In this setting, the assumption of
no direct effect of the instrument
(i.e., no effect not explained by
the measured variables (here A
and S)) is equivalent to  in
(8) and so may be tested by
testing .  This estimation
and testing may be problematic
where R consists of many
unordered categories and so the
dimension of  is high, as in
our example.
7.3 F a i l u r e - t i m e
outcomes
In our motivating example, death is common, and time to death is arguably the most
important outcome.  Our system of linear models will not work for the popular but
nonlinear Cox proportional hazards model (Cox, 1972),  but the approach can apply
to the accelerated failure-time model (AFTM), which is a linear model for the natural
logarithm of the failure-time (Cox and Oakes, 1984).  Henceforth, we use Y to denote
the log of the failure-time.  
In almost any study with failure-time outcomes, the failure-time will
sometimes be censored.  This complicates application of the methods discussed above,
as expectations  cannot be calculated using least squares.  This leaves two
alternatives for estimation: 1) assume a parametric form or distribution for the error
in , or use a semiparametric G-estimation approach.  Both approaches require
appropriate ways to deal with censoring.  We consider here two types of censoring:
fixed (modified type I censoring) and “random” censoring.  The first refers to planned
censoring, where a potential censoring time is known for all subjects, regardless of
whether a censoring event is actually observed.  Random censoring refers to loss to
follow-up or other reasons for unplanned or unpredictable censoring.  For fixed
censoring, one must use artificial censoring (Joffe and Brensinger, 2001; Robins,
1992; Robins et al. 1992) in the analysis.  Artificial censoring results in difficulties in
estimating the structural parameters  due in part to the fact that the function to be
Figure 4.  Causal diagram 3, augmented to
allow additional mediators of the effect of the
instrument.
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optimized is no longer continuous.  This complicates obtaining both point and interval
estimates.  Random censoring can be dealt with using inverse probability of censoring
weighting methods (Robins et al. 1992); these methods rely on the censoring process
being ignorable given the measured past. 
7.4 Time-varying auxiliary treatments
In many cases, both main and auxiliary treatments may vary over time.  In our
example, both VA and dialysis dose may vary within an individual.  Nonetheless, the
type of VA may vary less frequently (as some surgical procedure is required to
establish VA), and so we make the working assumption that VA is constant over an
extended period, while dialysis dose may vary over time.  In this setting, it is
appealing to consider modeling the effect of the auxiliary intervention received at each
point in time, then incorporating these effects  into estimates of the overall effect of
the main intervention.  We consider briefly how to extend our approach to this setting.
Let  denote the level of S that applies at each discrete time t, and let 
denote the entire history of S.  Consider first a model for the joint effects of A and S
on Y; a fairly general linear model is
The 2SLS approach (2) then becomes
to estimate distinct parameters, we will need the design matrix formed from each of
the individual elements in regression (10) to be full rank.  Collinearity may be a severe
problem if, as expected, the effect of R on the various s is similar.  Dimension
reduction may be helpful here; suppose that  is a low-dimension function of .
The simplest such function is , a common value for all t. 
Estimating the effect of A on S requires less modification; (3) generalizes to
and (4) becomes
(9)
(10)
(11)
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One can fit a separate model for each , or one can model various s jointly with
a common parameter , where the time-specific parameters  are
functions of . In the latter case, one will need to account for the nonindependence
of the various s in an individual in the variance calculation.  
It is easy to show that, generalizing (6), the overall effect  may be
calculated as
Variance calculations can be based on generalizations of the 2SLS or 3SLS estimators
considered in the appendix.  One can also use semiparametric G-estimators for  and
.
Estimation for failure-time outcomes with multiple measurements of the
auxiliary treatment S is more complicated.  Estimating the separate component effects
of A and S is straightforward, using G-estimation.  However, estimation of the overall
effect of A under IV-like assumptions is problematic.
To estimate the component effects of A and S, we use a structural nested
failure-time model (SNFTM).  Let  denote the level of S that applies at time t
measured in continuous time; we presume that  is constant on the interval
between discrete measurement times t.  The simplest SNFTM for this setting is an
AFTM with time-varying covariates: 
Model (14)  assumes no interaction between A and .  For a time-invariant ,
this reduces to the standard AFTM.  Estimation can use G-estimation, which is based
on testing the independence of  and R; for model (14),
this will require a 2 degree of freedom test.  
Estimation of the effect of A on S can also use a generalization of the method
(12)
(13)
(14)
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sketched above.  For now, we assume that, even though S may vary over time, the
effect of A on S is constant on average, i.e., in (11), , a constant.  We can use
2SLS or G-estimation methods to estimate .  As before, the overall effect can be
estimated as .
Inference under less restrictive assumptions is more complicated.  Consider
model (11) without the restriction of constant effects. We no longer have available a
simple formula for obtaining overall effects.  Let overlines denote the history of a
variable over time, thus,  denotes the history of .  To obtain overall effects, one
could in principle compute  from the data and models  for the effect of
A and S on Y and  for the effect of A on S.   One could then compare 
with  at an individual level, or average over a population, as a measure of
overall effects.  Let  denote the history of S that would be seen by
following the observed history through t, then setting  thereafter.  One could
in principle make this comparison by “blipping-up,” i.e., recursively computing 
from , , and  using a rank-preserving structural nested model.
Unfortunately, for a given individual,  will only be computable if  is
observed; if a subject fails before t and  is no longer observable, as would be true
if Y refers, even in part, to mortality,  will not be observable for .  If the
treatment A is beneficial overall at each point in time, so that , there will be
some times t for which we cannot compute  for some subjects.  If the treatment
is consistently harmful or failure never precludes observation of S subsequently, this
approach can be used together with the restrictive assumption of rank-preservation.
Appropriate coding of a so that large a is beneficial can finesse this issue.
8 Discussion
We have sketched an approach for estimating the overall effect of an exposure or
treatment in settings in which conventional analysis fails because of unmeasured
confounders.  Here, IV-type assumptions may be valid for estimating the joint effects
of the main and auxiliary treatments, but are not by themselves sufficient to identify
the overall effect of the main treatment.  So long as we can estimate the effect of the
main treatment on  the auxiliary one, we will be able to estimate the overall effect. 
While the relaxation of the no-unmeasured confounders assumption is
valuable, we have needed to substitute other assumptions.  These are comprised of
structural assumptions and modeling assumptions.  The structural assumptions
include: 1) the assumption that there are no effects of the IV on the main outcome
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except those mediated by measured variables (although this assumption is relaxed in
7.2), and 2) the assumption that the effect of the study treatment is deterministic (i.e.,
given one counterfactual and the true model, we could recover any other without
error).  Neither assumption is fully testable (Robins et al. 1992; Robins, 1994).  
The assumption of deterministic treatment effects, roughly equivalent to rank-
preservation, is often a heuristic for deriving and explaining estimation procedures,
but may impose no restrictions on the joint distribution of the observables when
compared with the less restrictive structural distribution models (Robins et al. 1992).
In these settings, analyses that heuristically assume rank preservation can be useful
(Robins et al. 1992; Ten Have et al. 2007).  While this is true in the simpler settings
in which both treatments are scalar, it is not true in general when the outcome is a
failure-time precluding observation of future auxiliary treatments .  Rank-
preservation will typically not be plausible; the reasonableness of analyses based on
the assumption remains to be determined.  Deterministic models are also not
compatible with binary or count outcomes.  Structural nested mean models and
associated G-estimation in principle may be used for these types of models and
outcomes.  For the usual logit link used with binary outcomes, both semiparametric
G-estimation and standard 2SLS approaches are problematic (Robins et al. 2000).
Extension of the methods presented here to these types of outcomes will require
further consideration.
We have also made some modeling assumptions, e.g., that the effects of the
main variables are correctly modeled in (1) and (3) using a linear model and do not
depend on each other or other measured variables.  These assumptions are partially
testable in some circumstances.  When there are more instruments than are needed for
identification (e.g., the dimension of W, V are 2 or greater in the setting of Appendix
1), the overidentifying restrictions test can be used to test these assumptions.  This
test basically uses the fact that if all the instruments are valid, then estimates based on
different subsets of instruments should agree up to sampling error (Anderson and
Rubin, 1949; Newey, 1985; Small, 2007).  
The no-interactions assumptions can also be tested by elaborating the models
to allow interactions, then testing the interaction terms.  The power of such tests may
be limited (Ten Have et al. 2007).  In the presence of such interactions, our approach
to estimating overall effects using (6) will fail.  For interactions between baseline
covariates X and the study treatments A and/or S, a relation like (6) may hold within
strata of X; therefore, overall effects within these strata may be estimated.  One can
then average these overall effects over the target population of interest to estimate
average overall effects for the population.
In our formulation, structural models (e.g., (1) and (3)) represent comparisons
of the observed outcome with a baseline potential outcome (e.g., of  with
).  Estimation of the marginal distribution of  using our approach depends on
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additional assumptions of no current treatment interaction, i.e., that the effect of A (or
S) is the same for subjects who receive A (S) and who do not receive it (Robins 1994;
Robins et al. 2000).  The same is true for estimation of overall effects (i.e.,
comparisons of ).
We expect that our analyses will be less efficient than standard adjustments for
confounding based on assumptions of ignorability of treatment assignment or no-
unmeasured confounders, just as IV analysis is generally less efficient than regression
adjustment for confounding.  This inefficiency can be heightened when estimating
multiple parameters in a single regression based on ignorability or randomization of
R (Ten Have et al. 2007), as we do here.  Thus, sample size requirements for studies
using our analysis can be substantially greater than conventional regression analyses.
Appendix 1. Details of variance estimation and three-stage
least squares estimation
In this appendix, we calculate analytically the standard errors for the two-stage least
squares estimator of the parameters of interest and describe how efficiency can be
improved by a three- stage least squares procedure.  We consider a setting
corresponding to the hemodialysis example in which A could be an ordinal or
continuous variable, S is a continuous variable and Y is a continuous variable.  More
specifically, we consider the following setting: 1) we have an i.i.d. sample of the
random vector ; 2)  (V and W are the subsets of X in equations (2)
and (4)); 3) an interaction between R and W affects A but not  and ; and 4) the
following models hold: 
where  denotes the linear projection.
We can then represent the observed data as: 
where  are mean zero “structural errors” with covariance matrix .  The
observed data forms a simultaneous equation system.  Note that the observed data can
be represented as 
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, where , .
Let  be the predicted value of A from the least squares regression of
A on .  Let  be the predicted value of S from the least squares
regression of S on .  Let .  Let
 and .
The 2SLS estimate of is .  The two stage least squares
estimate  is a consistent estimator of ; a consistent estimator of
 is , where  and  is the
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estimate of  that equals the sample covariance matrix of  (Amemiya,
1985; Ch. 7). 
A more efficient estimate of  can be obtained by the 3SLS procedure
(Amemiya 1985).  3SLS is a generalized least squares type version of 2SLS that takes
account of the covariance between .  The 3SLS estimate of  is
.  A consistent estimate of  is
.  Note that  is positive semi-
definite (Harris and Mátyás, 1999) so that  is asymptotically efficient relative to
.
Regardless of how we estimate , , and , we estimate the total effect
of the treatment A by  and we can estimate the variance of  using
the Delta Method: 
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